Inovio Pharmaceuticals, Inc. (NASDAQ:INO) President and CEO, Dr. J. Joseph Kim, presented a corporate overview at the 22nd Annual Emerald Groundhog Day Investment Forum on Thursday, February 5th. On Wednesday shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) closed at $7.50. Company’s sales growth for last 5 years was 45.10%.
On 29 January, Bellatrix Exploration Ltd. (NYSE: BXE) announced an updated 2015 net capital budget and operational outlook, and provides an update on its recent commodity price risk management activities. In response to continued volatility of oil and gas prices, Bellatrix announces an updated 2015 net capital budget of up to $200 million, reduced from the previously announced $300 million. Bellatrix Exploration Ltd. (NYSE:BXE) in last trading activity advanced 17.57% to close at $2.61. Company weekly performance is 20.28% while its quarterly performance stands at -43.01%. Bellatrix Exploration Ltd. (NYSE:BXE) is -75.61% away from its 52 week high.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST) announced that it has completed the previously announced underwritten public offering and concurrent private placement of its common stock. The Company raised $5.5 million in aggregate gross proceeds from the public offering and the private placement, which it intends to use for the continued development of product candidates through clinical trials and for working capital and general corporate purposes.
On last trading day Asterias Biotherapeutics, Inc. (NYSEMKT:AST) remains unchanged to close at $3.85. Its volatility for the week is 6.41% while volatility for the month is 6.46%. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) monthly performance is -19.79%.
MetLife (NYSE: MET) reported Q4 EPS of $1.38, $0.02 better than the analyst estimate of $1.36. Revenue for the quarter came in at $18.25 billion versus the consensus estimate of $18.18 billion. MetLife, Inc. (NYSE:MET) has 0.10% insider ownership while its institutional ownership stands at 75.40%. In last trading activity company’s stock closed at $50.41.
On 6 February, Kentucky First Federal Bancorp (NASDAQ:KFFB), announced net earnings of $579,000 or $0.07 diluted earnings per share for the three months ended December 31, 2014, compared to net earnings of $598,000 or $0.07 diluted earnings per share for the three months ended December 31, 2013, a decrease of $19,000 or 3.2% On last trading day Kentucky First Federal Bancorp (NASDAQ:KFFB) advanced 0.12% to close at $8.15. Its volatility for the week is 1.55% while volatility for the month is 0.86%. KFFB’s sales growth for past 5 years was 1.60% and its EPS growth for past 5 years was 18.10%. Kentucky First Federal Bancorp (NASDAQ:KFFB) monthly performance is 1.87%.